Chronic Kidney Disease in Cancer Survivors

As breakthroughs in cancer care are leading to improved long-term outcomes in a subset of advanced cancers, there is a growing population of long-term cancer survivors that are at risk of long-term complications. In this review, we summarize what is known about chronic kidney disease in cancer survi...

Full description

Saved in:
Bibliographic Details
Published inAdvances in chronic kidney disease Vol. 28; no. 5; pp. 469 - 476.e1
Main Authors Lee, Meghan, Wang, Qiyu, Wanchoo, Rimda, Eswarappa, Meghana, Deshpande, Priya, Sise, Meghan E.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.09.2021
Subjects
Cancer survivorship
Chemotherapy
Immunotherapy
Chemotherapy
Immunotherapy
Cancer survivorship
Online AccessGet full text

Cover

More Information
Summary:As breakthroughs in cancer care are leading to improved long-term outcomes in a subset of advanced cancers, there is a growing population of long-term cancer survivors that are at risk of long-term complications. In this review, we summarize what is known about chronic kidney disease in cancer survivors, focusing on the following high-risk groups: survivors of childhood cancers, stem cell transplant recipients, patients with renal cell carcinoma, patients exposed to cisplatin and other nephrotoxic chemotherapies, and patients receiving immunotherapy for cancer. As new anticancer therapies are developed, more research is needed to understand the long-term risks of kidney function decline and to devise methods to prevent chronic kidney disease. [Display omitted]
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:1548-5595
1548-5609
DOI:10.1053/j.ackd.2021.10.007